Navigation Links
United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
Date:10/20/2011

AMSTERDAM, October 20, 2011 /PRNewswire/ --

-- "Working Toward a Cure: Examining the State of Global Breast Cancer Research" Reveals Key Trends in Breast Cancer Research Article Output --

The United States, China and Switzerland lead the international scientific community in the publication of breast cancer research articles, according to the Elsevier research outlook report, Working Toward a Cure: Examining the State of Global Breast Cancer Research. By analyzing major trends in article output at the international, national and institutional levels, the research landscape outlook report highlights the dynamic nature of breast cancer research across the global research landscape. A detailed analysis of research productivity in the field was performed using Scopus data and SciVal® Spotlight, a web-based research performance and planning tool. Amongst the observations, China's output of articles pertaining to breast cancer research nearly doubled from 2006 to 2010.

"With an increasing focus on breast cancer research in China and other parts of Asia, implementation of meaningful clinical practices directed at breast cancer risk assessment, prevention, detection and diagnosis, and treatment, may keep this particular form of cancer under control," said W.B.Coleman, Ph.D., Professor and Director of Graduate Studies, UNC Lineberger Comprehensive Cancer Center.

Key findings from the report include:

  • The United States: Remains Leader in Breast Cancer Research Article Output

Despite static growth in breast cancer research output from 2006 to 2010, the United States continues as the most prolific producer of breast cancer research, publishing more than 900 articles in 2010.  Based on an analysis using Scopus data, Elsevier determined that the United States also remains a global leader in the number of article citations in other research papers
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
2. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
3. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
4. Full-day "United Nations" Online Investor Conference: October 6th at RetailInvestorConferences.com
5. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
6. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
7. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
8. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
11. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... a multi-arm Phase 1 study of MM-141, a bispecific ... in an oral session by Dr. Mansoor Saleh ... Research Annual Meeting in Philadelphia, PA. ... MM-141 as a monotherapy and in combination with everolimus ...
(Date:4/21/2015)... , April 21, 2015  Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... that Dr. Mark W. Sawicki , ... 3rd Annual BioLogistics Summit in San ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 PRC ... sponsor and exhibit at the ACRP 2015 Global Conference ... City, Utah. The Association of Clinical Research Professionals (ACRP) ... research conference solely focused on the conduct of clinical ... and development, and widely recognized industry certifications. , The ...
(Date:4/21/2015)... Mo. (PRWEB) April 21, 2015 A ... HOLLOWAY AMERICA is slated to discuss its custom fabrication ... present its reimagined website, which launched just prior to ... and Thurs. (April 21, 22 and 23) at the ... 12,000 representatives of the world’s largest and most innovative ...
Breaking Biology Technology:First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3
... AGREEMENT PROVIDES CORGENIX EXCLUSIVE WORLDWIDE RIGHTS TO ... FOR CARDIOVASCULAR INFLAMMATION, DENVER, March 18 ... a worldwide developer and marketer of,diagnostic test ... the Okayama,Prefecture Industrial Promotion Foundation covering new ...
... 18 Visionsense Corp. announces,FDA 510(k) Clearance ... Vision,System. The system is based on a ... targeting Minimal Invasive,laparoscopic and endoscopic Surgery (MIS)., ... enhances MIS surgical,procedures that are under served ...
... 18 /PRNewswire/ - Aegera Therapeutics announced today,the ... trial for AEG33773, a,novel, orally bioavailable small ... diabetic neuropathy. The Phase I study will ... AEG33773 using a randomized,double blind, placebo controlled, ...
Cached Biology Technology:Corgenix Signs Technology Licensing Agreement With Japanese Government 2Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain 2
(Date:4/20/2015)... Calif. , April 20, 2015 Huntington ... Gabriel Valley to implant a new miniaturized, wireless monitoring ... System is the first and only FDA-approved heart failure ... hospital admissions when used by physicians to manage heart ... sensor that is implanted in the pulmonary artery (PA) ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... virus (HCV) are at an increased risk of developing ... a study published in the May 8, 2007, issue ... Researchers from the National Cancer Institute (NCI), part of ... Medicine, found that HCV infection increased the risk of ...
... certain neurodegenerative diseases, such as mad cow disease or ... of infectious protein called a prion. Remarkably, in recent ... beneficial roles in biology, and prions even may act ... , But although prions have received a great deal ...
... central Catalonia, is so delicate that experts cannot get physically ... the years since the tracks were discovered they have been ... weathered and eroding at a rapid rate. , To ... near-vertical rock faces. , Palaeontologists feared the tracks could ...
Cached Biology News:Risk of lymphoma increases with hepatitis C virus infection 2Scientists identify prion's infectious secret 2Scientists identify prion's infectious secret 3Diminishing dinosaur steps saved by laser and laptop 2Diminishing dinosaur steps saved by laser and laptop 3
Request Info...
ANTI STENOTROPHOMONAS MALTOPHILIA...
... Phoretix 2D, Expression and Evolution supports data ... gel analysis studies in determining differential protein ... component Oracle data base plug ... client software). Supports advanced statistical ...
Request Info...
Biology Products: